drugset / Trial / NCT02672202

Shifting Pain Modulation From Pro-to Anti-nociceptive

NCT02672202

Terminated 9 enrolled Rambam Health Care Campus
RandomizedParallel-groupTriple-blindTreatment

Summary

To create a data base that will facilitate the enrichment of the insights regarding post-operative pain development, and to identify those individuals with the potential to develop this kind of pain. The identification will be based on the individualized pain modulation profile, composed of a battery of tests as detailed below.

Timeline

Start
2016-02
Primary completion
2017-05
Completion
2017-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Duloxetine Small molecule 60 mg
Comparator Pregabalin Small molecule 150 mg

Indications